{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:57:28Z","timestamp":1793908648721,"version":"4.8.0"},"reference-count":248,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the leading chronic liver disorder worldwide. Its pathological progression typically begins with hepatic steatosis, advances to metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, and in some cases culminates in hepatocellular carcinoma (HCC). This continuum is influenced not only by metabolic disturbances but also by coordinated local and systemic inflammatory and immune responses. This article systematically summarizes the inflammatory mechanisms underlying MASLD\/MASH progression, highlighting their origin in the dynamic crosstalk between innate and adaptive immune compartments. Such interactions involve multiple immune cell subsets, including macrophages, T lymphocytes, and B lymphocytes, and are governed by intricate molecular regulatory pathways. Furthermore, this review explores how these interconnected processes amplify hepatic inflammation and fibrogenesis and discusses potential therapeutic approaches to modulate key nodes within immune signaling networks.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1835197","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:40:12Z","timestamp":1782711612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune crosstalk in metabolic dysfunction-associated steatotic liver disease: interactions between innate and adaptive immunity"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiangqiong","family":"Li","sequence":"first","affiliation":[{"name":"Collge of Basic Medical Sciences, Yunnan University of Chinese Medicine","place":["Kunming, Yunnan, China"]},{"name":"Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunnu","family":"Jin","sequence":"additional","affiliation":[{"name":"Collge of Basic Medical Sciences, Yunnan University of Chinese Medicine","place":["Kunming, Yunnan, China"]},{"name":"Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindong","family":"Fang","sequence":"additional","affiliation":[{"name":"Collge of Basic Medical Sciences, Yunnan University of Chinese Medicine","place":["Kunming, Yunnan, China"]},{"name":"Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Ma","sequence":"additional","affiliation":[{"name":"Collge of Basic Medical Sciences, Yunnan University of Chinese Medicine","place":["Kunming, Yunnan, China"]},{"name":"Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"He","sequence":"additional","affiliation":[{"name":"Collge of Basic Medical Sciences, Yunnan University of Chinese Medicine","place":["Kunming, Yunnan, China"]},{"name":"Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancheng","family":"Lu","sequence":"additional","affiliation":[{"name":"Collge of Basic Medical Sciences, Yunnan University of Chinese Medicine","place":["Kunming, Yunnan, China"]},{"name":"Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangzhuang","family":"Jia","sequence":"additional","affiliation":[{"name":"Collge of Basic Medical Sciences, Yunnan University of Chinese Medicine","place":["Kunming, Yunnan, China"]},{"name":"Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhua","family":"Shi","sequence":"additional","affiliation":[{"name":"Collge of Basic Medical Sciences, Yunnan University of Chinese Medicine","place":["Kunming, Yunnan, China"]},{"name":"Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment","place":["Kunming, Yunnan, China"]},{"name":"Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32228","article-title":"Global burden of NAFLD and chronic liver disease among adolescents and young adults","volume":"75","author":"Paik","year":"2022","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9196","DOI":"10.3390\/ijms23169196","article-title":"mTOR: A potential new target in nonalcoholic fatty liver disease","volume":"23","author":"Feng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31889","article-title":"The emerging role of B cells in the pathogenesis of NAFLD","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/imr.13334","article-title":"Innate immunity-with an adaptive twist","volume":"323","author":"Josefowicz","year":"2024","journal-title":"Immunol Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000386","article-title":"Therapeutic modulation of the liver immune microenvironment","volume":"78","author":"Tilg","year":"2023","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-101320-031555","article-title":"Functional hallmarks of healthy macrophage responses: Their regulatory basis and disease relevance","volume":"40","author":"Sheu","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2020.09.006","article-title":"Lipid metabolism in regulation of macrophage functions","volume":"30","author":"Yan","year":"2020","journal-title":"Trends Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2018.01.020","article-title":"Macrophages and lipid metabolism","volume":"330","author":"Remmerie","year":"2018","journal-title":"Cell Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00675-6","article-title":"Macrophage functional diversity in NAFLD - more than inflammation","volume":"18","author":"Barreby","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100524","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0016","article-title":"Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance","volume":"59","author":"Huang","year":"2010","journal-title":"Diabetes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000928","article-title":"Single-cell profiling reveals hepatic monocyte-derived macrophages heterogeneity during steatotic liver disease","volume":"10","author":"Xu","year":"2026","journal-title":"Hepatol Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02407-8","article-title":"Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease","volume":"57","author":"Li","year":"2025","journal-title":"Nat Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.08.002","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.004","article-title":"Soluble TREM2 levels reflect the recruitment and expansion of TREM2(+) macrophages that localize to fibrotic areas and limit NASH","volume":"77","author":"Hendrikx","year":"2022","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32620","article-title":"Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness","volume":"77","author":"Indira Chandran","year":"2023","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001429","article-title":"MIF-mediated crosstalk between THRSP + hepatocytes and CD74 + lipid-associated macrophages in hepatic periportal zone drives MASH","volume":"83","author":"Xu","year":"2026","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/db23-0357","article-title":"Roles of activin A and gpnmb in metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"73","author":"Liu","year":"2024","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92902","article-title":"CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis","volume":"2","author":"Itoh","year":"2017","journal-title":"JCI Insight"},{"key":"B32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s42003-024-06357-5","article-title":"Egr2 drives the differentiation of Ly6C(hi) monocytes into fibrosis-promoting macrophages in metabolic dysfunction-associated steatohepatitis in mice","volume":"7","author":"Iwata","year":"2024","journal-title":"Commun Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01199-x","article-title":"Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20\/CCR6 axis in human hepatocellular carcinoma","volume":"21","author":"Wang","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature20611","article-title":"Identification of an atypical monocyte and committed progenitor involved in fibrosis","volume":"541","author":"Satoh","year":"2017","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI124616","article-title":"More friend than foe: the emerging role of neutrophils in tissue repair","volume":"129","author":"Peiseler","year":"2019","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175618","article-title":"Polyunsaturated fatty acids drive neutrophil extracellular trap formation in nonalcoholic steatohepatitis","volume":"945","author":"Wu","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"Wang","year":"2021","journal-title":"J Hepatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2024-0058","article-title":"Neutrophils in MASLD and MASH","volume":"58","author":"Shrestha","year":"2025","journal-title":"BMB Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trsl.2020.11.003","article-title":"Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets","volume":"231","author":"Miele","year":"2021","journal-title":"Transl Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"9380","DOI":"10.3390\/ijms23169380","article-title":"MicroRNA-223 suppresses human hepatic stellate cell activation partly via regulating the actin cytoskeleton and alleviates fibrosis in organoid models of liver injury","volume":"23","author":"Ariyachet","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2009.05.005","article-title":"Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection","volume":"112","author":"D'Amico","year":"2010","journal-title":"Acta Histochem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10020-019-0084-3","article-title":"Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes","volume":"25","author":"Mirea","year":"2019","journal-title":"Mol Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31031","article-title":"Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets","volume":"72","author":"Hwang","year":"2020","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31390","article-title":"Protective and detrimental roles of p38\u03b1 mitogen-activated protein kinase in different stages of nonalcoholic fatty liver disease","volume":"72","author":"Hwang","year":"2020","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41419-025-07376-8","article-title":"Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization","volume":"16","author":"Yang","year":"2025","journal-title":"Cell Death Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1337241","article-title":"Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1477187","article-title":"Gut microbiota mediated T cells regulation and autoimmune diseases","volume":"15","author":"Bhutta","year":"2024","journal-title":"Front Microbiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/jleuko\/qiad081","article-title":"Lipid metabolism in the immune niche of tumor-prone liver microenvironment","volume":"115","author":"Chen","year":"2024","journal-title":"J Leukoc Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23292","article-title":"Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis","volume":"51","author":"Kremer","year":"2010","journal-title":"Hepatology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1035950","article-title":"New insights into iNKT cells and their roles in liver diseases","volume":"13","author":"Gu","year":"2022","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115131","article-title":"State of CD8(+) T cells in progression from nonalcoholic steatohepatitis to hepatocellular carcinoma: From pathogenesis to immunotherapy","volume":"165","author":"Zhong","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13447","article-title":"Adipose invariant NKT cells interact with CD1d-expressing macrophages to regulate obesity-related inflammation","volume":"165","author":"Satoh","year":"2022","journal-title":"Immunology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00082","article-title":"The differential roles of T cells in non-alcoholic fatty liver disease and obesity","volume":"10","author":"Van Herck","year":"2019","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.76","article-title":"Decoding the role of immune T cells: A new territory for improvement of metabolic-associated fatty liver disease","volume":"2","author":"Liu","year":"2023","journal-title":"iMeta"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1569915","article-title":"The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00873","article-title":"Prominent receptors of liver sinusoidal endothelial cells in liver homeostasis and disease","volume":"11","author":"Pandey","year":"2020","journal-title":"Front Physiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403516","article-title":"Dissecting acute drug-induced hepatotoxicity and therapeutic responses of steatotic liver disease using primary mouse liver and blood cells in a liver-on-a-chip model","volume":"11","author":"Liu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00018-023-04966-7","article-title":"Liver endothelial cells in NAFLD and transition to NASH and HCC","volume":"80","author":"Velliou","year":"2023","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","author":"Gracia-Sancho","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159217","article-title":"Free fatty acids differentially downregulate chemokines in liver sinusoidal endothelial cells: Insights into non-alcoholic fatty liver disease","volume":"11","author":"McMahan","year":"2016","journal-title":"PloS One"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.95","article-title":"Pivotal role of liver sinusoidal endothelial cells in NAFLD\/NASH progression","volume":"95","author":"Miyao","year":"2015","journal-title":"Lab Invest"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i12.1272","article-title":"Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease","volume":"15","author":"Raza","year":"2023","journal-title":"World J Hepatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.012","article-title":"Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease","volume":"70","author":"Hammoutene","year":"2019","journal-title":"J Hepatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000207","article-title":"The evolving role of liver sinusoidal endothelial cells in liver health and disease","volume":"78","author":"McConnell","year":"2023","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02401","article-title":"Innate immune cells in immune tolerance after liver transplantation","volume":"9","author":"Huang","year":"2018","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci Transl Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10456-025-09969-5","article-title":"The role of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver diseases and liver cancer: Mechanisms and potential therapies","volume":"28","author":"Mo","year":"2025","journal-title":"Angiogenesis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: An update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.07.004","article-title":"Dendritic cell subsets and locations","volume":"348","author":"Balan","year":"2019","journal-title":"Int Rev Cell Mol Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100223","article-title":"The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells","volume":"207","author":"Crozat","year":"2010","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goae089","article-title":"Active role of the immune system in metabolic dysfunction-associated steatotic liver disease","volume":"12","author":"Mori","year":"2024","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092184","article-title":"Natural killer-dendritic cell interactions in liver cancer: Implications for immunotherapy","volume":"13","author":"Cazzetta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000515117","article-title":"Innate immune cells in the adipose tissue in health and metabolic disease","volume":"14","author":"Michailidou","year":"2022","journal-title":"J Innate Immun"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02255-y","article-title":"Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis","volume":"26","author":"Martin","year":"2025","journal-title":"Nat Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101819-025146","article-title":"Dendritic cell regulation of T helper cells","volume":"39","author":"Yin","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00006","article-title":"TCR signal strength alters T-DC activation and interaction times and directs the outcome of differentiation","volume":"7","author":"van Panhuys","year":"2016","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn1150","article-title":"HIVEP1 aggravates NASH by reprogramming polyamine metabolism in T(H)17 cells","volume":"17","author":"Ren","year":"2025","journal-title":"Sci Transl Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1104943","article-title":"The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone","volume":"13","author":"Zi","year":"2022","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20150405","article-title":"The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice","volume":"130","author":"Rolla","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835936","article-title":"The alterations in and the role of the Th17\/Treg balance in metabolic diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: Fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00790-w","article-title":"Activation of AMPK\u03b11 is essential for regulatory T cell function and autoimmune liver disease prevention","volume":"18","author":"Zhu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954798","article-title":"Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiology","volume":"13","author":"Malko","year":"2022","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1371089","article-title":"Immune regulation and therapeutic application of T regulatory cells in liver diseases","volume":"15","author":"Ajith","year":"2024","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i27.3346","article-title":"Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy","volume":"28","author":"Zhang","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1807","article-title":"The detrimental role of regulatory T cells in nonalcoholic steatohepatitis","volume":"6","author":"Dywicki","year":"2022","journal-title":"Hepatol Commun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","article-title":"Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis","volume":"57","author":"Savage","year":"2024","journal-title":"Immunity"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103806","article-title":"Role of regulatory T cells in inflammatory liver diseases","volume":"24","author":"Yang","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297923020104","article-title":"Interaction between adipocytes and B lymphocytes in human metabolic diseases","volume":"88","author":"Stasevich","year":"2023","journal-title":"Biochem (Mosc)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.09.020","article-title":"Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides","volume":"44","author":"Martin-Armas","year":"2006","journal-title":"J Hepatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1445634","article-title":"Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: Unveiling the critical role of T and B lymphocytes","volume":"15","author":"Cebi","year":"2024","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/ATVBAHA.114.303569","article-title":"Targeting B cells in atherosclerosis: Closing the gap from bench to bedside","volume":"35","author":"Tsiantoulas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2018.06.015","article-title":"B2-lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)","volume":"124","author":"Bruzz\u00ec","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000831","article-title":"Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells","volume":"81","author":"Feng","year":"2025","journal-title":"Hepatology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1561171","article-title":"Regulatory B cells, the key regulator to induce immune tolerance in organ transplantation","volume":"16","author":"Liao","year":"2025","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115553","article-title":"B cells in metabolic dysfunction-associated steatotic liver disease (MASLD): From mechanisms to therapeutic exploration","volume":"166","author":"Jia","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1447391","article-title":"The multifaceted roles of B lymphocytes in metabolic dysfunction-associated steatotic liver disease","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32428","article-title":"Dual roles of B lymphocytes in mouse models of diet-induced nonalcoholic fatty liver disease","volume":"76","author":"Karl","year":"2022","journal-title":"Hepatology"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003544","article-title":"Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion","volume":"138","author":"Yu","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32481","article-title":"The B side of B cells in NAFLD","volume":"76","author":"Barrow","year":"2022","journal-title":"Hepatology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"12377","DOI":"10.3390\/ijms232012376","article-title":"Role of B lymphocytes in the pathogenesis of NAFLD: A 2022 update","volume":"23","author":"Deng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115847","article-title":"PD-1(+)\/CXCR6(+)CD8(+)T lymphocytes promote MASLD Malignant progression through inflammatory and immune dysregulation","volume":"168","author":"Wang","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","article-title":"CD8(+) tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells","volume":"12","author":"Koda","year":"2021","journal-title":"Nat Commun"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101144","article-title":"METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000591","article-title":"Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma","volume":"79","author":"Li","year":"2024","journal-title":"Hepatology"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo4474","article-title":"Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease","volume":"14","author":"Fujiwara","year":"2022","journal-title":"Sci Transl Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2184991","article-title":"Anti-CD122 antibody restores specific CD8(+) T cell response in nonalcoholic steatohepatitis and prevents hepatocellular carcinoma growth","volume":"12","author":"Lacotte","year":"2023","journal-title":"Oncoimmunology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.70159","article-title":"Hepatic CD4 T cells predict hepatocellular carcinoma risk on metabolic dysfunction-associated steatohepatitis patients","volume":"14","author":"Rodriguez","year":"2026","journal-title":"United Eur Gastroenterol J"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5954437","article-title":"Increased PD-L1 restricts liver injury in nonalcoholic fatty liver disease","volume":"2022","author":"Dong","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1583597","article-title":"Unveiling B7\/CD28 family proteins in hepatocellular carcinoma: Insights into communication and prognostic significance","volume":"16","author":"Cai","year":"2025","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27233","article-title":"Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation","volume":"60","author":"Chatzigeorgiou","year":"2014","journal-title":"Hepatology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000733","article-title":"New emerging targets in cancer immunotherapy: CD137\/4-1BB costimulatory axis","volume":"4","author":"Etxeberria","year":"2020","journal-title":"ESMO Open"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1805","article-title":"Deficiency for costimulatory receptor 4-1BB protects against obesity-induced inflammation and metabolic disorders","volume":"60","author":"Kim","year":"2011","journal-title":"Diabetes"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30881","article-title":"4-1BB delineates distinct activation status of exhausted tumor-infiltrating CD8(+) T cells in hepatocellular carcinoma","volume":"71","author":"Kim","year":"2020","journal-title":"Hepatology"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8498-3","article-title":"OX40, OX40L and autoimmunity: A comprehensive review","volume":"50","author":"Webb","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2025.153143","article-title":"The expression of OX40 in CD4+ T cells and its association with hepatic fibrosis injury","volume":"230","author":"Xu","year":"2025","journal-title":"Immunobiology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1016\/j.celrep.2018.12.006","article-title":"OX40 regulates both innate and adaptive immunity and promotes nonalcoholic steatohepatitis","volume":"25","author":"Sun","year":"2018","journal-title":"Cell Rep"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2016.11.002","article-title":"CD40 signaling and hepatic steatosis: Unanticipated links","volume":"41","author":"Lepreux","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ccell.2022.08.004","article-title":"Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109930","article-title":"MiR-195 regulates CD40 to maintain Th17\/Treg balance in rats with non-alcoholic fatty liver disease","volume":"124","author":"Li","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B129","doi-asserted-by":"publisher","first-page":"14702","DOI":"10.1038\/s41598-019-50976-6","article-title":"Depletion of CD40 on CD11c(+) cells worsens the metabolic syndrome and ameliorates hepatic inflammation during NASH","volume":"9","author":"Aarts","year":"2019","journal-title":"Sci Rep"},{"key":"B130","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41419-021-03749-x","article-title":"Fas\/FasL mediates NF-\u03baBp65\/PUMA-modulated hepatocytes apoptosis via autophagy to drive liver fibrosis","volume":"12","author":"Tan","year":"2021","journal-title":"Cell Death Dis"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3614-z","article-title":"Circulating soluble Fas and Fas ligand levels are elevated in children with nonalcoholic steatohepatitis","volume":"60","author":"Alkhouri","year":"2015","journal-title":"Dig Dis Sci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41467-017-00566-9","article-title":"Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function","volume":"8","author":"Item","year":"2017","journal-title":"Nat Commun"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03568-2","article-title":"Author correction: Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH","volume":"593","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01594.x","article-title":"Fas ligand-induced apoptosis of hepatocytes in natural killer cell leukaemia","volume":"106","author":"Tani","year":"1999","journal-title":"Br J Haematol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20204","article-title":"Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice","volume":"39","author":"Ochi","year":"2004","journal-title":"Hepatology"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313155","article-title":"Adipose type I interferon signalling protects against metabolic dysfunction","volume":"67","author":"Wieser","year":"2018","journal-title":"Gut"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aai7616","article-title":"Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome","volume":"2","author":"Ghazarian","year":"2017","journal-title":"Sci Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88689","article-title":"IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans","volume":"1","author":"Alzaid","year":"2016","journal-title":"JCI Insight"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.119659","article-title":"Hepatic stellate cell-derived IL-11 exacerbates liver fibrosis via interplay between HSCs and macrophages","volume":"22","author":"Zhang","year":"2026","journal-title":"Int J Biol Sci"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041818-011649","article-title":"Hiding in plain sight: Interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation","volume":"71","author":"Cook","year":"2020","journal-title":"Annu Rev Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189889","article-title":"Anti-inflammatory effect of muscle-derived interleukin-6 and its involvement in lipid metabolism","volume":"22","author":"Nara","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28456","article-title":"Interleukin-1 and inflammasomes in alcoholic liver disease\/acute alcoholic hepatitis and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"64","author":"Tilg","year":"2016","journal-title":"Hepatology"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-0321","article-title":"Multiple roles of IL6 in hepatic injury, steatosis, and senescence aggregate to suppress tumorigenesis","volume":"81","author":"Shriki","year":"2021","journal-title":"Cancer Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12645","article-title":"Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice","volume":"35","author":"Yamaguchi","year":"2015","journal-title":"Liver Int"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26746","article-title":"IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice","volume":"59","author":"Harley","year":"2014","journal-title":"Hepatology"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-0417","article-title":"Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice","volume":"147","author":"den Boer","year":"2006","journal-title":"Endocrinology"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add1599","article-title":"NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis","volume":"8","author":"Marinovi\u0107","year":"2023","journal-title":"Sci Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Tan","year":"2013","journal-title":"J Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23837","article-title":"Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3","volume":"52","author":"Ki","year":"2010","journal-title":"Hepatology"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280620","article-title":"Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis","volume":"28","author":"Thompson","year":"1998","journal-title":"Hepatology"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1597204","article-title":"Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Supruniuk","year":"2025","journal-title":"Front Immunol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","article-title":"Therapeutic targeting of the complement system: From rare diseases to pandemics","volume":"73","author":"Garred","year":"2021","journal-title":"Pharmacol Rev"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100740","article-title":"Activated immune and complement C3 are potential contributors in MASH via stimulating neutrophil extracellular traps","volume":"14","author":"Liu","year":"2025","journal-title":"Cells"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23228","article-title":"Activation of the complement system in human nonalcoholic fatty liver disease","volume":"50","author":"Rensen","year":"2009","journal-title":"Hepatology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131902","article-title":"Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy","volume":"211","author":"Marshall","year":"2014","journal-title":"J Exp Med"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300038","article-title":"The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance","volume":"191","author":"Phieler","year":"2013","journal-title":"J Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00535-023-02002-w","article-title":"Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization","volume":"58","author":"Jiang","year":"2023","journal-title":"J Gastroenterol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.10.014","article-title":"Bridging innate and adaptive immunity: Understanding and targeting the complement system in GVHD pathogenesis and therapy","volume":"32","author":"Wu","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01089-1","article-title":"Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma","volume":"22","author":"Lau","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212190","article-title":"T cell subsets and natural killer cells in the pathogenesis of nonalcoholic fatty liver disease","volume":"22","author":"Gebru","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2024.102458","article-title":"Gut microbiota-NLRP3 inflammasome crosstalk in metabolic dysfunction-associated steatotic liver disease","volume":"48","author":"Yu","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: The interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02418","article-title":"Adapted immune responses of myeloid-derived cells in fatty liver disease","volume":"9","author":"Hundertmark","year":"2018","journal-title":"Front Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i20.2559","article-title":"Role of \u03b3\u03b4T cells in liver diseases and its relationship with intestinal microbiota","volume":"26","author":"Zhou","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41467-025-67034-7","article-title":"Lack of intestinal Mucin-1 impairs intestinal epithelial barrier and promotes metabolic dysfunction-associated steatotic liver disease in male mice","volume":"17","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128317","article-title":"Akkermansia muciniphila: A key player in gut microbiota-based disease modulation","volume":"301","author":"Shaheen","year":"2025","journal-title":"Microbiol Res"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl7209","article-title":"Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma","volume":"7","author":"Yamagishi","year":"2022","journal-title":"Sci Immunol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","article-title":"A human liver cell atlas reveals heterogeneity and epithelial progenitors","volume":"572","author":"Aizarani","year":"2019","journal-title":"Nature"},{"key":"B172","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat Commun"},{"key":"B173","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1038\/s41467-025-59985-8","article-title":"Hepatitis B virus surface antigen drives T cell immunity through non-canonical antigen presentation in mice","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003571","article-title":"TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8(+) T cell and XCR1(+) dendritic cell spatial co-localization","volume":"10","author":"Gardner","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000270","article-title":"Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression","volume":"78","author":"Guillot","year":"2023","journal-title":"Hepatology"},{"key":"B176","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41746-026-02352-8","article-title":"Integrating multi-omics and machine learning systematically deciphers cellular heterogeneity and fibrotic regulatory networks in the progression from MASLD to MASH","volume":"9","author":"Wen","year":"2026","journal-title":"NPJ Digit Med"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"B178","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1124\/pr.115.011395","article-title":"Glucagon-like peptide-1 and its class B G protein-coupled receptors: A long march to therapeutic successes","volume":"68","author":"Graaf","year":"2016","journal-title":"Pharmacol Rev"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.09.011","article-title":"Obesity, diabetes, and inflammation: Pathophysiology and clinical implications","volume":"58","author":"Donath","year":"2025","journal-title":"Immunity"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01307-5","article-title":"Immunopathogenic mechanisms and immunoregulatory therapies in MASLD","volume":"22","author":"He","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.240303","article-title":"GLP-1\/GLP-1R axis: From metabolism (obesity and T2DM) to immunity","volume":"15","author":"Kumar","year":"2025","journal-title":"Open Biol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13679-023-00519-y","article-title":"The role of tumor necrosis factor-alpha in the pathogenesis and treatment of nonalcoholic fatty liver disease","volume":"12","author":"Vachliotis","year":"2023","journal-title":"Curr Obes Rep"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2026.03.011","article-title":"The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors","volume":"14","author":"Gonzalez-Rellan","year":"2026","journal-title":"Cell Metab"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S524893","article-title":"Therapeutic targeting of PPAR\u03b3 in nonalcoholic fatty liver disease: Efficacy, safety, and drug development","volume":"19","author":"Zhou","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.17033","article-title":"Modulation of lipid metabolism and Keap1-Nrf2 pathway activation in macrophages by targeting PPAR\u03b3 affects NAFLD progression","volume":"40","author":"Chen","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1111\/jgh.15025","article-title":"Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4\/NF-\u03baB signaling pathway","volume":"35","author":"Wu","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v14.i7.1365","article-title":"Regulation of PPAR-\u03b3 activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease","volume":"14","author":"Li","year":"2022","journal-title":"World J Hepatol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000182","article-title":"Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines","volume":"78","author":"Gong","year":"2023","journal-title":"Hepatology"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112821","article-title":"MAFLD-related hepatocellular carcinoma: Exploring the potent combination of immunotherapy and molecular targeted therapy","volume":"140","author":"Guo","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v16.i9.842","article-title":"Mechanism of mesenchymal stem cells in liver regeneration: Insights and future directions","volume":"16","author":"Jin","year":"2024","journal-title":"World J Stem Cells"},{"key":"B194","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2022.08.037","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2\/NQO-1 pathway","volume":"192","author":"Kang","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833878","article-title":"Mesenchymal stem cell-derived extracellular vesicles in liver immunity and therapy","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"893","DOI":"10.7150\/ijbs.39725","article-title":"Mesenchymal stromal cells promote liver regeneration through regulation of immune cells","volume":"16","author":"Hu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1558194","article-title":"The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Qin","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Disco"},{"key":"B199","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"key":"B200","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13287-025-04197-6","article-title":"Huc-MSCs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through miR-24-3p\/STING axis","volume":"16","author":"Jiang","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr2201182","article-title":"Fighting cardiac fibrosis with CAR T cells","volume":"386","author":"Friedman","year":"2022","journal-title":"N Engl J Med"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","article-title":"Effects of Belapectin, an inhibitor of Galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension","volume":"158","author":"Chalasani","year":"2020","journal-title":"Gastroenterology"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J Hepatol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-025-01387-8","article-title":"Targeting inflammation with chimeric antigen receptor macrophages using a signal switch","volume":"9","author":"Cao","year":"2025","journal-title":"Nat BioMed Eng"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082048","article-title":"Telomeres and telomerase in the development of liver cancer","volume":"12","author":"In der Stroth","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.004","article-title":"Systemic treatment of hepatocellular carcinoma: An EASL position paper","volume":"75","author":"Bruix","year":"2021","journal-title":"J Hepatol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-023-01026-9","article-title":"Tremelimumab: A review in advanced or unresectable hepatocellular carcinoma","volume":"19","author":"France","year":"2024","journal-title":"Target Oncol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14889","article-title":"Non-alcoholic fatty liver disease is a potential risk factor for liver injury caused by immune checkpoint inhibitor","volume":"35","author":"Sawada","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-24-1088","article-title":"Targeting myeloid Trem2 reprograms the immunosuppressive niche and potentiates checkpoint immunotherapy in NASH-driven hepatocarcinogenesis","volume":"13","author":"Wang","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2300706120","article-title":"Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells","volume":"120","author":"Gu","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/ijc.34869","article-title":"Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation","volume":"154","author":"Kara-Ali","year":"2024","journal-title":"Int J Cancer"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1612567","article-title":"Nutritional status, immunonutrition, and gut microbiome: a coming of age for immunotherapy","volume":"16","author":"Mattavelli","year":"2025","journal-title":"Front Immunol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26188928","article-title":"Immunonutrition: Another player on the MASLD field","volume":"26","author":"L\u00f3pez-M\u00e9ndez","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103384","article-title":"N-3 polyunsaturated fatty acids and their lipid mediators as a potential immune-nutritional intervention: a molecular and clinical view in hepatic disease and other non-communicable illnesses","volume":"13","author":"Herrera Vielma","year":"2021","journal-title":"Nutrients"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113302","article-title":"Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): An update","volume":"12","author":"Barchetta","year":"2020","journal-title":"Nutrients"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2022.07.039","article-title":"Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: a systematic review of randomised controlled trials","volume":"41","author":"Miller","year":"2022","journal-title":"Clin Nutr"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac140","article-title":"Exploring visceral and subcutaneous adipose tissue secretomes in human obesity: implications for metabolic disease","volume":"163","author":"Kahn","year":"2022","journal-title":"Endocrinology"},{"key":"B218","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/DCR.0000000000000740","article-title":"Preoperative immunonutrition and elective colorectal resection outcomes","volume":"60","author":"Thornblade","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1177\/0148607103027005355","article-title":"Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients","volume":"27","author":"Heyland","year":"2003","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-1711-5","article-title":"Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial","volume":"29","author":"Bertolini","year":"2003","journal-title":"Intensive Care Med"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.4103\/jpgm.JPGM_693_17","article-title":"Combination of arginine, glutamine, and omega-3 fatty acid supplements for perioperative enteral nutrition in surgical patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST): a prospective, randomized, double-blind study","volume":"64","author":"Ma","year":"2018","journal-title":"Randomized Controlled Trial"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1039\/d3tb02766j","article-title":"Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders","volume":"12","author":"Chu","year":"2024","journal-title":"J Mater Chem B"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114378","article-title":"Nintedanib-amplified effects of HSP47 siRNA on liver fibrosis therapy by inhibiting collagen secretion","volume":"388","author":"Yang","year":"2025","journal-title":"J Control Release"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.2c05889","article-title":"Redox-unlockable nanoparticle-based MST1 delivery system to attenuate hepatic steatosis via the AMPK\/SREBP-1c signaling axis","volume":"14","author":"Li","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S452194","article-title":"Dual-stimuli-responsive gut microbiota-targeting nitidine chloride-CS\/PT-NPs improved metabolic status in NAFLD","volume":"19","author":"Lu","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121030","article-title":"Nanocapsule-mediated sustained H(2) release in the gut ameliorates metabolic dysfunction-associated fatty liver disease","volume":"276","author":"Jin","year":"2021","journal-title":"Biomaterials"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1271835","article-title":"Nanoparticles alleviate non-alcoholic steatohepatitis via ER stress sensor-mediated intestinal barrier damage and gut dysbiosis","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Microbiol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40164-025-00658-z","article-title":"Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma","volume":"14","author":"Yu","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1170207","article-title":"HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma","volume":"14","author":"Shen","year":"2023","journal-title":"Front Immunol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1039\/d0tb01826k","article-title":"Supramolecular hybrids of carbon dots and dihydroartemisinin for enhanced anticancer activity and mechanism analysis","volume":"8","author":"Li","year":"2020","journal-title":"J Mater Chem B"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116702","article-title":"Targeted delivery strategies: the interactions and applications of nanoparticles in liver diseases","volume":"175","author":"Meng","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i27.109105","article-title":"Gut microbiome-specific nanoparticle-based therapeutics for liver diseases","volume":"31","author":"Khurana","year":"2025","journal-title":"World J Gastroenterol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2015.26","article-title":"CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice","volume":"39","author":"Poggi","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"B234","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1172\/JCI38388","article-title":"Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice","volume":"120","author":"Wueest","year":"2010","journal-title":"J Clin Invest"},{"key":"B235","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1038\/s41467-021-23084-1","article-title":"A BAFF\/APRIL axis regulates obesogenic diet-driven weight gain","volume":"12","author":"Chan","year":"2021","journal-title":"Nat Commun"},{"key":"B236","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/s41598-018-37403-y","article-title":"Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease","volume":"9","author":"Nakamura","year":"2019","journal-title":"Sci Rep"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.06.006","article-title":"Polyunsaturated fatty acid-induced metabolic exhaustion and ferroptosis impair the anti-tumour function of MAIT cells in MASLD","volume":"83","author":"Deschler","year":"2025","journal-title":"J Hepatol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274582","article-title":"IL-23 signaling is not an important driver of liver inflammation and fibrosis in murine non-alcoholic steatohepatitis models","volume":"17","author":"Heredia","year":"2022","journal-title":"PloS One"},{"key":"B239","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12876-024-03245-4","article-title":"Hepatic recruitment of myeloid-derived suppressor cells upon liver injury promotes both liver regeneration and fibrosis","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.025","article-title":"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages(\u2606)","volume":"73","author":"Lefere","year":"2020","journal-title":"J Hepatol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111650","article-title":"Immunomodulatory functions of FXR","volume":"551","author":"Fiorucci","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00272-8","article-title":"Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial","volume":"8","author":"Harrison","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.1215","article-title":"Aspirin for metabolic dysfunction-associated steatotic liver disease without cirrhosis: a randomized clinical trial","volume":"331","author":"Simon","year":"2024","journal-title":"JAMA"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2024.171218","article-title":"Positive interplay between FFAR4\/GPR120, DPP-IV inhibition and GLP-1 in beta cell proliferation and glucose homeostasis in obese high fat fed mice","volume":"177","author":"Owolabi","year":"2024","journal-title":"Peptides"},{"key":"B246","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12951-025-03512-w","article-title":"Advancing liver cancer treatment with dual-targeting CAR-T therapy","volume":"23","author":"Yang","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122318","article-title":"Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers","volume":"302","author":"Balaji","year":"2023","journal-title":"Biomaterials"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.10.044","article-title":"Hepatic stellate cell-targeted chemo-gene therapy for liver fibrosis using fluorinated peptide-lipid hybrid nanoparticles","volume":"376","author":"Lai","year":"2024","journal-title":"J Control Release"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1835197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:40:15Z","timestamp":1782711615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1835197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":248,"alternative-id":["10.3389\/fimmu.2026.1835197"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1835197","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1835197"}}